Share This Article
At approximately 5 to 6 weeks of gestation, the development of a baby’s airways begins. The tiny air tubes (bronchioles) that connect the larger air passages to the terminal air sacs (alveoli) in the lungs may fail to form properly. This developmental anomaly leads to the formation of cysts—fluid-filled sac-like pockets—in the affected lung. This condition is known as congenital pulmonary airway malformation (CPAM), previously referred to as congenital cystic adenomatoid malformation.
In nearly 98% of cases, CPAM affects only one lung. The condition is usually diagnosed before birth during routine prenatal ultrasounds and varies in severity. Some cases resolve on their own, while others require surgical intervention after birth.
Understanding CPAM and Its Types
Each lung is divided into sections called lobes. CPAM usually affects one lobe, which continues to receive normal blood flow. Studies indicate that CPAM is slightly more common in male fetuses than in female fetuses. CPAM is classified into three types based on ultrasound characteristics:
Type I (Macrocystic CPAM): Accounts for about 50% of cases and consists of one or multiple large cysts, ranging from 2 to 10 cm in diameter.
Type II (Microcystic CPAM): Represents around 40% of cases and is characterized by multiple small cysts, each less than 2 cm in diameter.
Type III (Solid-appearing CPAM): Occurs in approximately 10% of cases and appears as a solid mass rather than cystic formations.
Other fetal lung abnormalities that can occur alongside CPAM include:
Bronchopulmonary Sequestration (BPS): A mass of non-functioning lung tissue receiving blood from the aorta instead of the pulmonary circulation.
Hybrid Lung Lesions: A combination of CPAM and BPS, consisting of both cystic and solid components.
Bronchial Atresia: A condition in which the major airway (bronchus) fails to develop properly, causing the affected lung to appear bright (echogenic) on ultrasound.
Symptoms of CPAM
While many babies with CPAM are asymptomatic at birth, some may experience respiratory distress due to the presence of a large lung mass. In severe cases, the mass can compress the lungs and heart, making it difficult for the baby to breathe. This may result in impaired cardiac function, requiring immediate medical intervention. Newborns who experience breathing difficulties are often placed in intensive care and may require oxygen support or mechanical ventilation before undergoing surgery to remove the mass.
Causes of CPAM
The exact cause of CPAM remains unknown. It is believed to result from abnormal lung development during early gestation, but no definitive genetic or environmental factors have been identified. While CPAM is generally not linked to inherited conditions, ongoing research aims to better understand its origins.
Complications of CPAM
CPAM can lead to several complications, especially when the mass is large. If the CPAM is big enough to shift the fetal heart to the opposite side of the chest, additional problems may arise. One method to assess CPAM severity is the congenital pulmonary airway malformation volume ratio (CVR). A CVR greater than 1.6 indicates a high risk for complications.
Potential complications include:
Polyhydramnios: Excess amniotic fluid accumulation due to fetal swallowing difficulties caused by CPAM.
Hydrops Fetalis: A life-threatening condition characterized by fluid buildup in multiple fetal compartments, including the lungs, abdomen, heart, and skin.
Placentomegaly: Fluid accumulation in the placenta, which can lead to pregnancy complications.
Approximately 10% of CPAM cases develop hydrops, which significantly increases the risk of fetal demise if left untreated. Certain types of CPAM, particularly Type II, are sometimes associated with additional congenital anomalies, such as cardiac defects and kidney malformations.
Diagnosis of CPAM
CPAM is commonly detected during a routine anatomy ultrasound around 20 weeks of pregnancy. The ultrasound may reveal a cystic or solid lung mass, sometimes causing a visible shift of the heart. In more detailed evaluations, a fetal MRI or fetal echocardiogram (specialized ultrasound of the baby’s heart) may be performed to assess the extent of the condition.
Treatment Options for CPAM
The management of CPAM depends on the severity of the condition. Some cases resolve spontaneously before birth, while others require medical intervention.
Prenatal Management:
If the CPAM is large or causing complications, doctors may monitor the fetus closely with frequent ultrasounds.
In certain cases, a shunt (small tube) may be inserted into the fetal chest to drain fluid from the cystic mass.
Steroids may be administered to shrink the CPAM if the CVR is high.
If hydrops develops or the mass continues to grow, early delivery via cesarean section may be recommended.
Postnatal Treatment:
If the baby is born with respiratory distress, immediate medical support will be provided.
A CT scan is usually performed between 2 to 3 months of age to determine the need for surgery.
Surgical removal of CPAM, typically via minimally invasive thoracoscopic surgery, is recommended between 3 to 6 months of age to prevent future complications.
Some asymptomatic cases may still require surgery to reduce the risk of infections and malignancy later in life.
FAQs About CPAM
1. What is the usual treatment for CPAM?
The standard treatment is surgical removal of the abnormal lung tissue between 6 to 9 months after birth. Before surgery, infants with a high-risk CPAM are closely monitored through regular ultrasounds and medical evaluations.
2. Are there any abnormalities associated with CPAM?
Type II CPAM is sometimes associated with congenital anomalies affecting other organs, such as the heart, kidneys, and digestive tract. However, Type I and Type III CPAMs are less commonly linked to other malformations.
3. Can CPAM resolve on its own?
In some cases, CPAM shrinks before birth and does not require surgical intervention. However, regular follow-ups are necessary to monitor any potential complications.
4. What is the long-term prognosis for babies with CPAM?
With early detection and appropriate management, the prognosis for CPAM is generally favorable. Most children who undergo surgery have normal lung function and lead healthy lives. However, untreated CPAM can increase the risk of recurrent lung infections or malignancy in later years.
5. Can CPAM be prevented?
Since the exact cause of CPAM is unknown, there are no specific preventive measures. However, early prenatal care and routine ultrasounds can aid in early detection and timely intervention.
Congenital pulmonary airway malformation (CPAM) is a rare but manageable lung condition that can be detected before birth. While some cases resolve on their own, others require close monitoring and surgical treatment. Advances in fetal imaging and neonatal care have improved outcomes for affected infants, allowing them to lead normal, healthy lives. If you or a loved one is expecting a baby diagnosed with CPAM, consulting a specialist in pediatric surgery or fetal medicine can help determine the best course of action for a positive outcome.